AviClear
FDA-cleared 1726nm laser targeting sebaceous glands for acne
이 치료에 대해
AviClear is the world's first FDA-cleared acne-specific laser. Its 1726nm wavelength selectively targets lipids in sebaceous glands, suppressing sebum at the source. Unlike traditional acne treatments that "manage" symptoms, AviClear addresses the root cause.
3 treatments required; 90% of patients show improvement at 6 months, 92% maintain ≥50% clearance at 12 months. Emerging as an isotretinoin alternative.
작용 기전
1726nm wavelength has high absorption coefficient for sebum (lipids) with relatively low absorption by melanin and water. This selectively heats sebaceous glands, inducing sebocyte apoptosis and sustained reduction in sebum production. Proprietary intelligent cooling system protects epidermis.
적응증
기대 효과
90% of patients show acne improvement at 6 months. 92% maintain ≥50% clearance at 12 months. Phase III trials confirm efficacy across mild, moderate, and severe acne. Long-lasting results reduce need for ongoing medication.
임상 근거
위험 및 부작용
Moderate treatment pain (reduced by cooling system). Transient redness/swelling (resolves within hours). Rare burns or blisters. Careful settings for darker skin (Fitzpatrick V-VI). Makeup allowed immediately after.